We are live on ! Find out more
BSX icon

Boston Scientific

888 hedge funds and large institutions have $54.6B invested in Boston Scientific in 2021 Q4 according to their latest regulatory filings, with 121 funds opening new positions, 290 increasing their positions, 322 reducing their positions, and 95 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 95

1% more funds holding

Funds holding: 877888 (+11)

3% less capital invested

Capital invested by funds: $56.3B → $54.6B (-$1.66B)

10% less repeat investments, than reductions

Existing positions increased: 290 | Existing positions reduced: 322

1.09% less ownership

Funds ownership: 91.5%90.41% (-1.1%)

18% less funds holding in top 10

Funds holding in top 10: 119 (-2)

42% less call options, than puts

Call options by funds: $271M | Put options by funds: $467M

Holders
888
Holders Change
+11
Holders Change %
+1.25%
% of All Funds
13.67%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.14%
New
121
Increased
290
Reduced
322
Closed
95
Calls
$271M
Puts
$467M
Net Calls
-$196M
Net Calls Change
-$17.7M
Name Holding Trade Value Shares
Change
Change in
Stake
SOADOR
226
State of Alaska Department of Revenue
Alaska
$9.62M +$324K +7,700 +4%
US Bancorp
227
US Bancorp
Minnesota
$9.53M -$97.4K -2,318 -1%
YCM
228
Yousif Capital Management
Michigan
$9.33M +$9.23M +219,694 New
MSL
229
Mackay Shields LLC
New York
$9.03M -$188K -4,470 -2%
PAM
230
Premier Asset Management
Illinois
$8.65M +$8.55M +203,545 New
LMIM
231
Lockheed Martin Investment Management
Maryland
$8.59M
II
232
IFM Investors
Australia
$8.4M +$202K +4,800 +2%
TPSF
233
Texas Permanent School Fund
Texas
$8.34M -$996K -23,698 -11%
FAT
234
First American Trust
California
$8.32M +$249K +5,933 +3%
Federated Hermes
235
Federated Hermes
Pennsylvania
$8.27M +$7.65M +181,962 +1,429%
MOACM
236
Mutual of America Capital Management
New York
$8.01M +$59.7K +1,420 +0.8%
IG
237
ING Group
Netherlands
$7.94M +$2.76M +65,739 +54%
GW
238
GW & Wade
Massachusetts
$7.8M -$30.6K -728 -0.4%
FNT
239
First National Trust
Pennsylvania
$7.78M +$7.7M +183,200 New
COPPSERS
240
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$7.6M +$18K +429 +0.2%
Group One Trading
241
Group One Trading
Illinois
$7.38M -$392K -9,328 -5%
SCI
242
S&CO Inc
Massachusetts
$7.22M -$840 -20 -0%
BBVA
243
Banco Bilbao Vizcaya Argentaria
Spain
$7.2M +$1.27M +30,196 +22%
FP
244
Financial Perspectives
Minnesota
$7.09M +$158K +3,756 +2%
FVWA
245
Foster Victor Wealth Advisors
South Carolina
$7.05M +$1.23M +29,376 +23%
Comerica Bank
246
Comerica Bank
Texas
$7.02M -$355K -8,457 -5%
BFM
247
Boothbay Fund Management
New York
$6.98M +$1.29M +30,785 +23%
GF
248
Gabelli Funds
New York
$6.92M
NIPH
249
NN Investment Partners Holdings
Netherlands
$6.92M -$240K -5,720 -3%
MLICM
250
Metropolitan Life Insurance Company (MetLife)
New York
$6.91M -$194K -4,611 -3%

BSX Hedge Fund Activity: Q4 2021 in Review

888 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q4 2021, worth a combined $54.6B — down 3% from $56.3B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new BSX positions and 95 closed out — a net gain of 26 holders — while 290 added to existing stakes and 322 trimmed.

The largest buyer was Viking Global Investors, adding an estimated $508M. The largest seller was Wellington Management Group, cutting an estimated $391M.

  • 888 institutional investors held Boston Scientific (BSX) as of Q4 2021, up from 877 in Q3 2021.
  • Funds reported $54.6B of Boston Scientific stock for Q4 2021, down 3% quarter-over-quarter.
  • 121 funds opened new Boston Scientific positions in Q4 2021 and 95 closed out, a net change of +26 holders.
  • The largest Boston Scientific buyer in Q4 2021 was Viking Global Investors, an estimated $508M added.
  • The largest Boston Scientific seller in Q4 2021 was Wellington Management Group, an estimated $391M sold.

Based on aggregated 13F filings for Q4 2021.